ng-nitroarginine methyl ester has been researched along with EHS Tumor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bisland, SK; Flitney, FW; Fricker, SP; Hirst, DG; Kennovin, GD; Pritchard, RJ | 1 |
| Delbro, D; Lundholm, K; Svanberg, E; Wang, W | 1 |
2 other study(ies) available for ng-nitroarginine methyl ester and EHS Tumor
| Article | Year |
|---|---|
Antitumor actions of ruthenium(III)-based nitric oxide scavengers and nitric oxide synthase inhibitors.
Topics: Animals; Enzyme Inhibitors; Free Radical Scavengers; Male; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Organometallic Compounds; Pentetic Acid; Rats; Ruthenium; Sarcoma, Experimental; Transplantation, Isogeneic; Tumor Burden | 2011 |
NOS isoenzyme content in brain nuclei as related to food intake in experimental cancer cachexia.
Topics: Animals; Body Weight; Brain; Cachexia; Dinoprostone; Eating; Enzyme Inhibitors; Female; Immunohistochemistry; Interleukin-6; Isoenzymes; Mice; Mice, Inbred C57BL; Neurons; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitroarginine; Proto-Oncogene Proteins c-fos; Radioimmunoassay; Sarcoma, Experimental; Time Factors | 2005 |